Early research (Phase 1)Study completedNCT06444048
What this trial is testing
Phase 1, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of an Enterovirus D68-specific Monoclonal Antibody in Healthy Adults
Who this might be right for
Enterovirus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 36